Ovarian Cancer Symptoms: Warning Signs to Know

Ovarian Cancer Symptoms: Not Silent, But Subtle

Ovarian cancer symptoms are real — but they are non-specific, gradual, and easily attributed to far more common conditions like irritable bowel syndrome, urinary tract infection, or general gastrointestinal discomfort. This is why ovarian cancer is so often diagnosed at an advanced stage: not because it produces no warning signs, but because the warning signs it does produce are easily dismissed, both by women themselves and by their healthcare providers.

Research published in the journal Cancer by Dr. Barbara Goff and colleagues in 2007 was pivotal in establishing that ovarian cancer does produce a recognizable symptom pattern — and that pattern is distinct enough from benign conditions to be clinically useful when properly evaluated. The Goff study surveyed over 1,700 women, including those with ovarian cancer, those with other gynecological conditions, and healthy women, and identified four symptoms that were significantly more common, more frequent, and more severe in women with ovarian cancer than in the comparison groups: bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and urinary urgency or frequency.

The critical insight from this research is not just which symptoms to look for, but how to assess them: symptoms that are new (developed within the past year), persistent (present more than 12 times per month), and more severe than usual are the ones that warrant prompt medical evaluation. Symptoms that match this profile — especially in women over 50 or in women with risk factors for ovarian cancer — should not be attributed to functional GI or urinary causes without appropriate evaluation to exclude a pelvic mass.

The Four Key Ovarian Cancer Symptoms

The four symptoms most reliably associated with ovarian cancer — validated by the Goff et al. ovarian cancer symptom index and subsequently confirmed in multiple studies — are:

1. Bloating

Persistent abdominal bloating is the most commonly reported symptom in women ultimately diagnosed with ovarian cancer. The bloating of ovarian cancer is characteristically different from the transient, diet-related bloating that most people experience periodically. It is:

• Present most days rather than intermittently
• Progressive — worsening over weeks or months rather than resolving
• Not relieved by passing gas, having a bowel movement, or avoiding gas-producing foods
• Associated with visible abdominal distension — the abdomen appears larger than usual, and clothing may no longer fit at the waist

The bloating of ovarian cancer can result from several mechanisms: the ovarian tumor itself occupying space in the pelvis and abdomen; ascites (fluid accumulation in the peritoneal cavity, which occurs when cancer cells spread to the peritoneal surface and stimulate fluid production); or impairment of normal bowel motility by peritoneal disease. In early-stage ovarian cancer, bloating may be subtle; in advanced disease with significant ascites, the abdominal distension can be severe and the abdomen visibly protuberant. For a focused explanation of this specific symptom and its causes in ovarian cancer, see our article on ovarian cancer bloating.

2. Pelvic or Abdominal Pain

Persistent pelvic or abdominal pain or discomfort is the second most commonly reported ovarian cancer symptom. This pain may be:

• Located in the lower abdomen or pelvis, sometimes unilateral (one side) early in disease
• Dull, aching, or pressure-like in character rather than sharp or colicky
• Present most days and not clearly related to the menstrual cycle
• Accompanied by a sensation of fullness or heaviness in the pelvis

In early-stage ovarian cancer, pelvic pain may result from the tumor stretching the ovarian capsule, torsion (twisting) of the ovary or a cyst on the ovary, or pressure of a growing mass on adjacent structures. In advanced disease with peritoneal spread, diffuse abdominal pain and discomfort from peritoneal implants is more common.

3. Difficulty Eating or Feeling Full Quickly (Early Satiety)

Women with ovarian cancer frequently report that they feel full very quickly when eating — after only a few bites of food — or that their appetite has markedly decreased. This symptom (called early satiety) is particularly significant because it is less commonly attributed to purely functional causes and more likely to prompt investigation. Possible mechanisms include:

• A pelvic or abdominal mass compressing the stomach or bowel and reducing the volume of food the stomach can accommodate before distension
• Ascitic fluid filling the abdominal cavity and creating pressure on the stomach
• Functional changes in gastric motility associated with peritoneal disease
• Systemic tumor-related metabolic changes affecting appetite regulation

4. Urinary Urgency or Frequency

Women with ovarian cancer may experience a new and persistent need to urinate more often than usual or with more urgency than before — feelings similar to those of a urinary tract infection, without the burning or other UTI symptoms. The pelvic mass may compress the bladder, reducing its functional capacity and triggering more frequent voiding. These urinary symptoms are notable because they may appear early in the disease when the tumor is still primarily confined to the pelvis, before abdominal symptoms from peritoneal spread develop.

Less Common Ovarian Cancer Symptoms

Beyond the four key symptoms, women with ovarian cancer may also experience:

• Back pain: Lower back pain, often dull and persistent, may result from a pelvic mass pressing on lumbar or sacral nerves or from retroperitoneal lymph node involvement in advanced disease.
• Fatigue: Unexplained, persistent fatigue that is out of proportion to activity level and does not improve with rest is a common cancer-associated symptom. Fatigue in ovarian cancer may reflect anemia (from chronic disease or iron deficiency), metabolic effects of active malignancy, or poor nutrition from early satiety.
• Menstrual irregularities: Changes in menstrual cycle frequency, duration, or flow — or intermenstrual bleeding in premenopausal women — may occur with ovarian tumors that produce hormones (sex cord-stromal tumors such as granulosa cell tumors produce estrogen, which can disrupt the normal hormonal regulation of the menstrual cycle).
• Postmenopausal vaginal bleeding: While not a primary ovarian cancer symptom (postmenopausal bleeding is more characteristic of endometrial cancer), it can occur with granulosa cell tumors that produce estrogen, stimulating the uterine endometrium to proliferate and bleed.
• Pain during intercourse (dyspareunia): A pelvic mass can cause discomfort or pain during sexual intercourse, particularly with deep penetration. New onset dyspareunia in a woman over 40 or postmenopausal woman warrants pelvic evaluation.
• Unintentional weight loss: Unexplained weight loss despite normal or reduced food intake can reflect cancer cachexia — the metabolic syndrome associated with many advanced malignancies, including ovarian cancer.
• Constipation or change in bowel habits: A pelvic mass can compress the rectosigmoid colon, causing constipation or difficulty passing stool. In advanced disease with diffuse peritoneal implants, bowel obstruction can occur.

Why Ovarian Cancer Symptoms Are So Often Missed

The most important reason ovarian cancer symptoms are frequently misattributed is that they overlap almost completely with the symptoms of far more common conditions. A woman experiencing bloating, abdominal discomfort, and changes in urination is statistically far more likely to have irritable bowel syndrome, a urinary tract infection, endometriosis, uterine fibroids, or functional dyspepsia than ovarian cancer. Clinicians correctly consider the most common diagnoses first — but when empirical treatment for these common conditions fails to resolve symptoms, the possibility of ovarian cancer should be reconsidered and appropriate evaluation pursued.

Several patterns have been identified in studies of ovarian cancer diagnosis delays:

• Women with ovarian cancer see an average of 2–3 different physicians before diagnosis
• Approximately one-third of women report that their symptoms were initially attributed to stress, anxiety, or a functional condition
• GI symptoms (bloating, early satiety) are particularly prone to attribution to IBS, gastritis, or dietary causes
• Urinary symptoms are frequently treated empirically as UTI without urine culture confirmation, delaying recognition that symptoms may reflect a pelvic mass rather than infection

The key clinical distinction between ovarian cancer symptoms and benign GI or urinary conditions is the pattern of symptoms: ovarian cancer symptoms are characteristically new (rather than a long-standing pattern), daily or near-daily (rather than intermittent), progressive (worsening over weeks to months), and not clearly linked to specific triggers (food intake, stress, menstrual cycle). Benign functional conditions like IBS, while chronic, typically have a longer history, a more variable day-to-day pattern, and some correlation with identifiable triggers.

Ovarian Cancer Symptoms by Subtype

Different types of ovarian cancer can produce different symptom patterns:

High-grade serous carcinoma (HGSC): The most common type, HGSC is typically diagnosed at Stage III or IV because it causes minimal symptoms until disease has spread widely throughout the peritoneum. When symptoms do develop, they typically reflect peritoneal involvement: diffuse abdominal bloating, early satiety from ascites, abdominal pain, and occasionally shortness of breath from pleural effusion (fluid around the lungs).

Low-grade serous carcinoma: Often more indolent than HGSC; may cause similar but more slowly progressive symptoms. More likely to be diagnosed at an earlier stage because of slower growth.

Granulosa cell tumors and other sex cord-stromal tumors: These hormone-producing tumors can cause symptoms related to excess estrogen production: postmenopausal vaginal bleeding (from endometrial stimulation), menstrual irregularities in premenopausal women, or — in girls — precocious puberty with early breast development and vaginal bleeding. The hormonal symptoms of sex cord-stromal tumors often prompt earlier evaluation, which is partly why these tumors have better survival statistics than HGSC.

Germ cell tumors (dysgerminoma, yolk sac tumor, immature teratoma): These tumors occur primarily in young women and adolescents and often grow rapidly, causing acute pelvic pain, abdominal mass, or torsion. Because they tend to present as acute rather than insidious symptoms and occur in a younger age group, they are often diagnosed at earlier stages.

Borderline (low malignant potential) tumors: These epithelial tumors are slow-growing and may remain asymptomatic for extended periods or present with mild pelvic discomfort. They are more frequently discovered incidentally on pelvic ultrasound or at time of surgery for another indication.

Distinguishing Ovarian Cancer from Benign Conditions

Several benign conditions cause symptoms that closely overlap with ovarian cancer and are far more common:

Irritable bowel syndrome (IBS): IBS causes bloating, abdominal pain, and changes in bowel habits. Key distinguishing features: IBS symptoms are typically long-standing (not new), often linked to specific food triggers or stress, frequently relieved by defecation, and associated with alternating constipation and diarrhea rather than progressive abdominal fullness. Ovarian cancer bloating is typically new, progressive, and not relieved by bowel movements.

Ovarian cysts: Benign ovarian cysts are extremely common, particularly in premenopausal women. Simple ovarian cysts cause similar pelvic discomfort and may cause urinary symptoms if large. TVUS distinguishes simple cysts (thin-walled, no internal complexity, usually resolve spontaneously) from complex masses requiring further evaluation.

Uterine fibroids: Fibroids can cause pelvic pressure, urinary frequency, and abdominal fullness similar to ovarian cancer. Pelvic examination and TVUS readily distinguish uterine fibroids from ovarian masses.

Endometriosis: Endometriosis causes chronic pelvic pain, dyspareunia, and dysmenorrhea that can mimic ovarian cancer symptoms. Endometriosis is also a risk factor for certain types of ovarian cancer (endometrioid and clear cell carcinoma), so women with endometriosis who develop new or worsening symptoms should have pelvic imaging performed.

How Symptoms Lead to Diagnosis

When a woman presents with symptoms consistent with possible ovarian pathology, the initial evaluation typically includes:

1. History and physical examination: Assessment of symptom duration, frequency, and severity; pelvic examination to assess for adnexal mass, uterine size, or other abnormalities.
2. Transvaginal ultrasound (TVUS): The primary imaging modality for evaluating the ovaries. TVUS can identify ovarian masses and characterize features that raise concern for malignancy (solid components, internal septations with nodularity, papillary projections, increased blood flow on Doppler).
3. CA-125 blood test: Elevated CA-125 combined with an adnexal mass on TVUS substantially increases concern for malignancy and may trigger referral to a gynecologic oncologist. CA-125 is not a reliable screening test in asymptomatic women but is appropriate in the evaluation of symptomatic women with an adnexal mass. Learn more about this test in our article on the CA-125 test.
4. CT or MRI: Cross-sectional imaging is used to characterize the extent of disease, assess for peritoneal implants or lymph node involvement, and plan surgical approach.
5. Surgical evaluation: Definitive diagnosis requires histological examination of tumor tissue, typically obtained at surgery. In most cases where ovarian cancer is suspected, diagnostic and therapeutic surgery are performed together.

Emergency Ovarian Symptoms

Some ovarian conditions require emergency evaluation and should not be confused with the gradual, persistent symptoms of ovarian cancer:

Ovarian torsion: Sudden, severe unilateral pelvic pain — often described as sharp, cramping, or colicky — accompanied by nausea and vomiting. Ovarian torsion occurs when the ovary (or an ovarian cyst or mass) twists on its pedicle, cutting off blood supply. It is a surgical emergency requiring immediate laparoscopy to detorse (untwist) the ovary and preserve ovarian function. Ovarian torsion can occur with ovarian masses, including malignant ones, but also with large benign cysts.

Ruptured ovarian cyst: Sudden onset of pelvic pain, often following physical activity or intercourse, that may be sharp and severe. Most ruptured cysts resolve with conservative management (pain control, rest), but cysts that rupture with significant intraperitoneal hemorrhage require surgical intervention.

Neither of these conditions presents with the gradual, progressive symptom pattern of ovarian cancer — they present acutely and require emergency evaluation.

Frequently Asked Questions

Can ovarian cancer be completely asymptomatic?

True complete absence of symptoms is uncommon — most women with ovarian cancer do experience symptoms before diagnosis, as established by Goff et al. However, symptoms may be so mild or so consistent with common benign conditions that women do not recognize them as unusual or do not seek evaluation for them. This is why ovarian cancer appears “silent” in retrospect: the symptoms were present but were not attributed to ovarian cancer at the time.

I had a normal Pap smear. Does that mean I do not have ovarian cancer?

No. The Pap smear screens for cervical cancer only and provides no information about the ovaries. A normal Pap smear result does not rule out ovarian cancer. Women experiencing persistent bloating, pelvic pain, early satiety, or urinary urgency should specifically ask about evaluation of the ovaries (pelvic exam, TVUS, CA-125), regardless of recent normal Pap smear results.

My CA-125 is normal. Does that mean I do not have ovarian cancer?

Not necessarily. CA-125 is elevated in only about 50% of Stage I ovarian cancers and in fewer than 80% of all ovarian cancers. A normal CA-125 does not rule out early ovarian cancer. Conversely, CA-125 can be elevated in many benign conditions including endometriosis, fibroids, pelvic inflammatory disease, and other cancers. CA-125 is most useful in combination with transvaginal ultrasound and clinical assessment, not as a standalone rule-out test.

What are the risk factors that should lower the threshold for evaluation?

Women who should have a lower threshold for evaluation when experiencing ovarian cancer-type symptoms include those with: known BRCA1 or BRCA2 mutation; Lynch syndrome; first-degree relative with ovarian cancer; personal history of breast cancer (particularly ER-negative); endometriosis; age over 50 (postmenopausal women); or prior unexplained pelvic abnormalities on imaging. For a comprehensive review of these risk factors, see our guide to ovarian cancer risk factors.

How to Talk to Your Doctor About Ovarian Cancer Symptoms

One of the most important steps a woman can take when she notices persistent, new symptoms is to communicate them clearly and specifically to her healthcare provider. Vague reporting — “I’ve been feeling bloated lately” — is more likely to result in empirical management of the most common cause, rather than investigation for a less common but serious one. More specific reporting — “I have been experiencing daily abdominal bloating for the past six weeks that is new for me, different from anything I have had before, and is not relieved by passing gas or changing my diet” — gives the provider information that is harder to dismiss as routine functional variation.

Useful language to use when describing ovarian cancer symptoms to your doctor:

• “This symptom is new — I have not experienced this pattern before.”
• “This is happening most days — more than 12 times per month.”
• “It has been going on for more than a month without improvement.”
• “It is not related to what I eat or my menstrual cycle.”
• “I would like a pelvic examination and transvaginal ultrasound to evaluate my ovaries.”

If you have been evaluated for a symptom and the initial explanation does not result in improvement with treatment, follow up and ask explicitly whether ovarian evaluation has been ruled out. You have the right to request a second opinion, to ask for a referral to a gynecologist or gynecologic oncologist, and to be taken seriously when you report that your symptoms are new, persistent, and interfering with your daily life.

The Importance of Knowing Your Family History

Women with a family history of ovarian, breast, or colorectal cancer — or who carry BRCA1, BRCA2, or Lynch syndrome gene mutations — have substantially elevated lifetime risk of ovarian cancer compared to the general population. BRCA1 mutation carriers have an approximately 35–46% lifetime risk of developing ovarian cancer; BRCA2 mutation carriers have an approximately 13–23% lifetime risk. For these high-risk women, the threshold for evaluation of ovarian symptoms should be lower, and ongoing surveillance with periodic transvaginal ultrasound and CA-125 testing in consultation with a gynecologic oncologist or high-risk specialist may be recommended even in the absence of symptoms.

If you do not know your family history of cancer, now is an excellent time to gather this information from family members. Knowledge of a first-degree relative (mother, sister, daughter) with ovarian cancer is one of the strongest clinical cues to request thorough evaluation when ovarian symptoms are present.

For a full discussion of who is at highest risk, genetic testing options, and risk-reduction strategies including risk-reducing salpingo-oophorectomy for BRCA carriers, see our comprehensive guide to ovarian cancer risk factors.